RCKT
Rocket Pharmaceuticals Inc
NASDAQ: RCKT · HEALTHCARE · BIOTECHNOLOGY
$3.48
+0.00% today
Updated 2026-04-30
Market cap
$379.93M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.01
Dividend yield
—
52W range
$2 – $8
Volume
3.7M
Rocket Pharmaceuticals Inc (RCKT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | $0.00 | $45000.00 | $169000.00 | $204000.00 | $330000.00 | $426000.00 | $1.15M | $5.37M | $6.27M | $7.10M | $9.38M | $11.03M |
| Gross profit | — | — | $0.00 | $-45000.00 | $-169000.00 | $-204000.00 | $-330000.00 | $-426000.00 | $-1.15M | $-5.37M | $-6.27M | $-7.10M | $-9.38M | $-11.03M |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $3.54M | $5.33M | $5.59M | $12.55M | $31.98M | $14.19M | $53.27M | $58.62M | $106.38M | $125.48M | $165.57M | $186.34M | $171.24M | $142.01M |
| SG&A | $2.31M | $1.32M | $2.11M | $7.84M | $9.89M | $12.54M | $17.89M | $17.53M | $27.92M | $41.77M | $58.77M | $73.32M | $101.96M | $86.50M |
| Operating income | $-5.85M | $-6.65M | $-7.70M | $-20.40M | $-41.88M | $-26.74M | $-71.16M | $-76.15M | $-136.00M | $-167.25M | $-224.34M | $-259.66M | $-273.20M | $-228.52M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-5.84M | $-6.73M | $-7.70M | $-20.26M | $-41.27M | $-26.74M | $-71.16M | $-71.14M | $-131.59M | $-157.81M | $-213.69M | $-236.62M | $-247.49M | $-210.21M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-5.84M | $-6.74M | $-7.70M | $-20.31M | $-41.44M | $-26.94M | $-71.49M | $-71.56M | $-132.73M | $-163.18M | $-219.95M | $-243.72M | $-256.86M | $-221.23M |
| Interest expense | $213000.00 | $884000.00 | $980000.00 | $1.23M | $1.42M | $3.58M | $5.24M | $4.78M | $7.55M | $5.89M | $1.91M | $1.88M | $1.89M | $1.89M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.06M | $-7.62M | $-9.53M | $-67.98M | $-42.85M | $-29.50M | $-74.52M | $-83.23M | $-146.67M | $-169.07M | $-221.86M | $-245.59M | $-258.75M | $-223.12M |
| Net income growth (YoY) | — | -25.7% | -25.1% | -613.3% | +37.0% | +31.2% | -152.6% | -11.7% | -76.2% | -15.3% | -31.2% | -10.7% | -5.4% | +13.8% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — |